First COVID-19, then Kawasaki-like Disease in Children

July 24, 2020

Children with COVID-19 can develop pediatric, inflammatory multisystemic syndrome, or PIMS, which can lead to symptoms similar to that of a painful vasculitis condition called Kawasaki disease. Today we talk with Jagadeesh Bayry, Ph.D., and Caroline Galeotti, M.D., of the University of Paris who recently described in Nature Reviews Rheumatology related pediatric cases they saw in their clinic.

Osteoporosis Screening May Be Necessary for Younger Postmenopausal Women

July 23, 2020

Osteoporosis isn't unique to older women, according to a review published in JAMA. At-risk younger women should be screened as well. In this Q&A, Dr. Carolyn J. Crandall of UCLA discusses osteoporosis screening in younger postmenopausal women.

Vitamin D Exposure for Optimal Bone Health

July 22, 2020

Managing vitamin D levels may not be as straightforward as it would seem. There are factors that should be considered that are not often communicated to patients. In today's edition of Overdrive, the Rheumatology Network podcast, we talk with Dr. Suzanne Jan de Beur of Johns Hopkins University School of Medicine. She serves as director of endocrinology at Johns Hopkins Bayview Medical Center and president-elect of the American Society for Bone and Mineral Research.

Treatment Combo Successfully Resolves Cytokine Storm in COVID-19

July 21, 2020

High doses of methylprednisoline with tocilizumab (if needed) successfully resolved COVID-19-associated cytokine storm syndrome in treated patients, doctors report.

Rheumatology Network News Roundup: Lupus

July 17, 2020

In this week’s news roundup from Rheumatology Network, we talk with Dr. Chrstine Anastasiou, a rheumatologist with the University of California San Francisco who recently published a study in Arthritis Care and Research that finds significant improvements in mortality for hospitalized patients in the U.S. with systemic lupus, but there remains a high mortality rate among blacks and Hispanics with SLE, and, now among Asian/Pacific Islanders with the condition. Learn more in this interview.

Repeat ANA Testing Holds Little Value

July 16, 2020

This study suggests that doctors may want to reconsider allowing repeat antinuclear antibody (ANA) testing. Repeat tests are expensive and hold little value, shows this study from The Lancet Rheumatology.

Image IQ: Joint Pain and Rash

July 16, 2020

A few weeks after a camping trip in Connecticut, a 24-year-old woman went to her local urgent care center with flu-like symptoms of myalgia, arthralgias, headache, and fever. She reported having an annular lesion on her leg shortly after the trip. Can you diagnose this patient?

New RA Biosimilar Approved for U.S. Market

July 14, 2020

The U.S. FDA has approved the sixth biosimilar to Humira, adalimumab-FKJP (Hulio), which will be available in the United States in 2023 for rheumatoid arthritis, psoriatic arthritis, psoriasis, juvenile arthritis and other conditions.

FDA Approves Treatment for Still's Disease

July 14, 2020

The U.S. FDA has approved the first treatment for adult-onset Still's disease, a rare form of systemic juvenile idiopathic arthritis associated with high fever, arthritis and rash.

Guselkumab Approved for Psoriatic Arthritis

July 14, 2020

The U.S. Food and Drug Administration has approved the first IL-23 inhibitor for moderate to severe psoriatic arthritis. The newly approved treatment, guselkumab, has been shown to improve the signs and symptoms of fatigue associated with PsA.